ArticleBrain research2019

Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice.

Yan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.